The National Coalition on Black Civic Participation (NCBCP) will host a historic celebration honoring Melanie L. Campbell’s ...

The Boys and Girls Club of County was one of eight clubs nationwide awarded funding to expand its science, technology, engineering and mathematics (STEM) programming. Timika Thrasher, the CEO of the ...

The third-quarter 2025 reporting cycle for the Medical sector is about to pick up pace this week, as most firms are slated to ...

Buying $1000 In GILD: If an investor had bought $1000 of GILD stock 20 years ago, it would be worth $9,831.49 today based on a price of $120.19 for GILD at the time of writing.

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Gilead (GILD), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the ...

Patients with advanced triple negative breast cancer ineligible for immunotherapy may overcome their typically poor prognosis with antibody-drug conjugates, suggest two trials presented at ESMO 2025.

This long-acting antiretroviral medicine offers protection for six months at a time, providing a transformative alternative for millions. The post SA first in Africa to approve ‘most effective’ HIV ...

Eli Lilly has agreed to acquire eye disease specialist Adverum Biotechnologies, bucking a recent trend of big pharma ...

The Inflammatory Diseases Market, valued at USD 22.5 billion in 2025, is projected to reach USD 34.9 billion by 2035, ...

The South African Health Products Regulatory Authority has approved a new HIV prevention injection called Lenacapavir.

South Africa has become the first African country – and our medicines regulator the third worldwide – to register the ...

South Africa has become the first African country, and our medicines regulator the third worldwide, to register the ...